Fluorine in PDB 7n4q: Bruton'S Tyrosine Kinase in Complex with Compound 45

Enzymatic activity of Bruton'S Tyrosine Kinase in Complex with Compound 45

All present enzymatic activity of Bruton'S Tyrosine Kinase in Complex with Compound 45:
2.7.10.2;

Protein crystallography data

The structure of Bruton'S Tyrosine Kinase in Complex with Compound 45, PDB code: 7n4q was solved by C.M.Metrick, D.J.Marcotte, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 5.00 / 1.50
Space group P 21 21 2
Cell size a, b, c (Å), α, β, γ (°) 72.088, 104.802, 38.183, 90, 90, 90
R / Rfree (%) 18.9 / 22

Other elements in 7n4q:

The structure of Bruton'S Tyrosine Kinase in Complex with Compound 45 also contains other interesting chemical elements:

Chlorine (Cl) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Bruton'S Tyrosine Kinase in Complex with Compound 45 (pdb code 7n4q). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Bruton'S Tyrosine Kinase in Complex with Compound 45, PDB code: 7n4q:

Fluorine binding site 1 out of 1 in 7n4q

Go back to Fluorine Binding Sites List in 7n4q
Fluorine binding site 1 out of 1 in the Bruton'S Tyrosine Kinase in Complex with Compound 45


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Bruton'S Tyrosine Kinase in Complex with Compound 45 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F701

b:24.4
occ:1.00
F1 A:0B9701 0.0 24.4 1.0
C14 A:0B9701 1.4 25.6 1.0
C15 A:0B9701 2.3 25.1 1.0
C13 A:0B9701 2.4 23.2 1.0
CD1 A:ILE472 3.5 31.2 1.0
C16 A:0B9701 3.6 24.4 1.0
C12 A:0B9701 3.6 20.6 1.0
CD2 A:LEU542 3.7 22.4 1.0
C17 A:0B9701 4.1 25.3 1.0
SD A:MET437 4.2 39.1 0.5
O A:HOH836 4.2 36.1 1.0
CD1 A:LEU542 4.2 25.3 1.0
CB A:PHE413 4.3 41.4 1.0
CG1 A:ILE432 4.3 26.8 1.0
CD A:LYS430 4.4 27.1 1.0
CD1 A:ILE432 4.6 30.9 1.0
CG A:LEU542 4.6 22.0 1.0
CG1 A:ILE472 4.8 28.4 1.0
N3 A:0B9701 4.8 21.1 1.0
O A:PHE413 4.9 37.8 1.0
CB A:LYS430 4.9 24.5 1.0

Reference:

B.T.Hopkins, E.Bame, N.Bell, T.Bohnert, J.K.Bowden-Verhoek, M.Bui, M.T.Cancilla, P.Conlon, P.Cullen, D.A.Erlanson, J.Fan, T.Fuchs-Knotts, S.Hansen, S.Heumann, T.J.Jenkins, C.Gua, Y.Liu, Y.Liu, M.Lulla, D.Marcotte, I.Marx, B.Mcdowell, E.Mertsching, E.Negrou, M.J.Romanowski, D.Scott, L.Silvian, W.Yang, M.Zhong. Utilizing Structure Based Drug Design and Metabolic Soft Spot Identification to Optimize the in Vitro Potency and in Vivo Pharmacokinetic Properties Leading to the Discovery of Novel Reversible Bruton'S Tyrosine Kinase Inhibitors. Bioorg.Med.Chem. V. 44 16275 2021.
ISSN: ESSN 1464-3391
PubMed: 34314938
DOI: 10.1016/J.BMC.2021.116275
Page generated: Fri Aug 2 09:56:36 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy